Deloitte Boosts Public Health Transformation by Acquiring End Point's Disease Surveillance Business

Tuesday, June 04, 2024

Deloitte has expanded its Public Health Transformation team through the acquisition of significant assets from End Point, notably their respected disease surveillance business, CasePointer.

This acquisition brings on board a wealth of talent, including software engineers, cloud developers, DevOps engineers, epidemiologists, and former public health officials.

End Point's team is renowned for its expertise in implementing EpiTrax, an open-source platform designed for collecting, organizing, and managing epidemiological data.

Combined with Deloitte's GovConnect™ digital assets, this collaboration aims to empower public health agencies to more effectively identify, investigate, and mitigate communicable diseases, environmental hazards, and bioterrorism events, while enhancing emergency response efforts.

Deloitte Consulting LLP and leader of Deloitte's public health transformation, expressed enthusiasm about the acquisition, stating, "This addition enhances our arsenal of high-quality tools for public health.

End Point's team, along with their robust solutions, align perfectly with Deloitte's expertise, offering public health officials an unprecedented opportunity to leverage cutting-edge technologies tailored to their communities' needs."

Principal at Deloitte Consulting LLP and leader of Deloitte's government and public services industry, emphasized the strategic significance of the acquisition in expanding Deloitte's suite of tools for health and human services agencies.

"This acquisition reinforces our commitment to innovation and industry expertise, allowing us to deliver mission-critical solutions to our public health clients more effectively."

Principal at Deloitte Consulting LLP and leader of Deloitte's state, local, and higher education sector, highlighted the potential impact of End Point's disease surveillance team on reinforcing America's public health infrastructure.

"Their expertise in open-source software and their talented team will enhance Deloitte's capabilities in disease reporting, case investigation, and outbreak management, benefiting government health organizations nationwide."

Transitioned to Deloitte with the acquisition, expressed excitement about the collaboration. "We look forward to leveraging Deloitte's resources and expertise to serve a broader client base and make a greater impact in government health organizations," he said.

It's important to note that Deloitte's acquisition specifically pertains to assets related to End Point's CasePointer business, with all other business lines remaining under End Point's ownership.


Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital Congress